Mesalamine, also known as Mesalamine, or 5-aminosalicylic acid (5-ASA), is a medication used to treat inflammatory bowel disease, including ulcerative colitis and Crohn's disease. It is generally used for mildly to moderately severe disease. It is taken by mouth or rectally. The formulations which are taken by mouth appear to be similarly effective.
The global market for Mesalamine was estimated to be worth US$ 156.5 million in 2023 and is forecast to a readjusted size of US$ 195.6 million by 2030 with a CAGR of 3.2% during the forecast period 2024-2030
The industry's leading manufacturers are Syntese A/S, Divis Laboratories, ipca Laboratories and Cambrex Corporation, which accounted for 23.74%, 14.71%, 6.44% and 6.35% of the global revenue share in 2019, respectively.
In terms of regions, the revenue share of Europe is the highest, reaching 41.11% in 2019.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Mesalamine, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Mesalamine by region & country, by Type, and by Application.
The Mesalamine market size, estimations, and forecasts are provided in terms of sales volume (MT) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Mesalamine.
Market Segmentation
By Company
Syntese A/S
Divis Laboratories
Cambrex Corporation
Ipca Laboratories
Hangzhou Brother
PharmaZell
Lianyungang Fengheng Biopharm
Lasa Loboratory
Erregierre SpA
Corden Pharma Bergamo
CTX Lifescience
Ishita Active Pharma Ingredients
YC Biotech (Jiangsu)
Xinxiang Tianfeng Fine Chemical
Segment by Type:
Purity ≥ 97%
Purity ≥ 98%
Purity ≥ 99%
Segment by Application
Mesalazine Tablets
Mesalazine Capsules
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Mesalamine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Mesalamine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Mesalamine in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Market Overview
1.1 Mesalamine Product Introduction
1.2 Global Mesalamine Market Size Forecast
1.2.1 Global Mesalamine Sales Value (2019-2030)
1.2.2 Global Mesalamine Sales Volume (2019-2030)
1.2.3 Global Mesalamine Sales Price (2019-2030)
1.3 Mesalamine Market Trends & Drivers
1.3.1 Mesalamine Industry Trends
1.3.2 Mesalamine Market Drivers & Opportunity
1.3.3 Mesalamine Market Challenges
1.3.4 Mesalamine Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Mesalamine Players Revenue Ranking (2023)
2.2 Global Mesalamine Revenue by Company (2019-2024)
2.3 Global Mesalamine Players Sales Volume Ranking (2023)
2.4 Global Mesalamine Sales Volume by Company Players (2019-2024)
2.5 Global Mesalamine Average Price by Company (2019-2024)
2.6 Key Manufacturers Mesalamine Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Mesalamine Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Mesalamine
2.9 Mesalamine Market Competitive Analysis
2.9.1 Mesalamine Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Mesalamine Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mesalamine as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Purity ≥ 97%
3.1.2 Purity ≥ 98%
3.1.3 Purity ≥ 99%
3.2 Global Mesalamine Sales Value by Type
3.2.1 Global Mesalamine Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Mesalamine Sales Value, by Type (2019-2030)
3.2.3 Global Mesalamine Sales Value, by Type (%) (2019-2030)
3.3 Global Mesalamine Sales Volume by Type
3.3.1 Global Mesalamine Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Mesalamine Sales Volume, by Type (2019-2030)
3.3.3 Global Mesalamine Sales Volume, by Type (%) (2019-2030)
3.4 Global Mesalamine Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Mesalazine Tablets
4.1.2 Mesalazine Capsules
4.1.3 Others
4.2 Global Mesalamine Sales Value by Application
4.2.1 Global Mesalamine Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Mesalamine Sales Value, by Application (2019-2030)
4.2.3 Global Mesalamine Sales Value, by Application (%) (2019-2030)
4.3 Global Mesalamine Sales Volume by Application
4.3.1 Global Mesalamine Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Mesalamine Sales Volume, by Application (2019-2030)
4.3.3 Global Mesalamine Sales Volume, by Application (%) (2019-2030)
4.4 Global Mesalamine Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Mesalamine Sales Value by Region
5.1.1 Global Mesalamine Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Mesalamine Sales Value by Region (2019-2024)
5.1.3 Global Mesalamine Sales Value by Region (2025-2030)
5.1.4 Global Mesalamine Sales Value by Region (%), (2019-2030)
5.2 Global Mesalamine Sales Volume by Region
5.2.1 Global Mesalamine Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Mesalamine Sales Volume by Region (2019-2024)
5.2.3 Global Mesalamine Sales Volume by Region (2025-2030)
5.2.4 Global Mesalamine Sales Volume by Region (%), (2019-2030)
5.3 Global Mesalamine Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Mesalamine Sales Value, 2019-2030
5.4.2 North America Mesalamine Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Mesalamine Sales Value, 2019-2030
5.5.2 Europe Mesalamine Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Mesalamine Sales Value, 2019-2030
5.6.2 Asia Pacific Mesalamine Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Mesalamine Sales Value, 2019-2030
5.7.2 South America Mesalamine Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Mesalamine Sales Value, 2019-2030
5.8.2 Middle East & Africa Mesalamine Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Mesalamine Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Mesalamine Sales Value
6.2.1 Key Countries/Regions Mesalamine Sales Value, 2019-2030
6.2.2 Key Countries/Regions Mesalamine Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Mesalamine Sales Value, 2019-2030
6.3.2 United States Mesalamine Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Mesalamine Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Mesalamine Sales Value, 2019-2030
6.4.2 Europe Mesalamine Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Mesalamine Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Mesalamine Sales Value, 2019-2030
6.5.2 China Mesalamine Sales Value by Type (%), 2023 VS 2030
6.5.3 China Mesalamine Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Mesalamine Sales Value, 2019-2030
6.6.2 Japan Mesalamine Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Mesalamine Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Mesalamine Sales Value, 2019-2030
6.7.2 South Korea Mesalamine Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Mesalamine Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Mesalamine Sales Value, 2019-2030
6.8.2 Southeast Asia Mesalamine Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Mesalamine Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Mesalamine Sales Value, 2019-2030
6.9.2 India Mesalamine Sales Value by Type (%), 2023 VS 2030
6.9.3 India Mesalamine Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Syntese A/S
7.1.1 Syntese A/S Company Information
7.1.2 Syntese A/S Introduction and Business Overview
7.1.3 Syntese A/S Mesalamine Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Syntese A/S Mesalamine Product Offerings
7.1.5 Syntese A/S Recent Development
7.2 Divis Laboratories
7.2.1 Divis Laboratories Company Information
7.2.2 Divis Laboratories Introduction and Business Overview
7.2.3 Divis Laboratories Mesalamine Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Divis Laboratories Mesalamine Product Offerings
7.2.5 Divis Laboratories Recent Development
7.3 Cambrex Corporation
7.3.1 Cambrex Corporation Company Information
7.3.2 Cambrex Corporation Introduction and Business Overview
7.3.3 Cambrex Corporation Mesalamine Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Cambrex Corporation Mesalamine Product Offerings
7.3.5 Cambrex Corporation Recent Development
7.4 Ipca Laboratories
7.4.1 Ipca Laboratories Company Information
7.4.2 Ipca Laboratories Introduction and Business Overview
7.4.3 Ipca Laboratories Mesalamine Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Ipca Laboratories Mesalamine Product Offerings
7.4.5 Ipca Laboratories Recent Development
7.5 Hangzhou Brother
7.5.1 Hangzhou Brother Company Information
7.5.2 Hangzhou Brother Introduction and Business Overview
7.5.3 Hangzhou Brother Mesalamine Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Hangzhou Brother Mesalamine Product Offerings
7.5.5 Hangzhou Brother Recent Development
7.6 PharmaZell
7.6.1 PharmaZell Company Information
7.6.2 PharmaZell Introduction and Business Overview
7.6.3 PharmaZell Mesalamine Sales, Revenue and Gross Margin (2019-2024)
7.6.4 PharmaZell Mesalamine Product Offerings
7.6.5 PharmaZell Recent Development
7.7 Lianyungang Fengheng Biopharm
7.7.1 Lianyungang Fengheng Biopharm Company Information
7.7.2 Lianyungang Fengheng Biopharm Introduction and Business Overview
7.7.3 Lianyungang Fengheng Biopharm Mesalamine Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Lianyungang Fengheng Biopharm Mesalamine Product Offerings
7.7.5 Lianyungang Fengheng Biopharm Recent Development
7.8 Lasa Loboratory
7.8.1 Lasa Loboratory Company Information
7.8.2 Lasa Loboratory Introduction and Business Overview
7.8.3 Lasa Loboratory Mesalamine Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Lasa Loboratory Mesalamine Product Offerings
7.8.5 Lasa Loboratory Recent Development
7.9 Erregierre SpA
7.9.1 Erregierre SpA Company Information
7.9.2 Erregierre SpA Introduction and Business Overview
7.9.3 Erregierre SpA Mesalamine Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Erregierre SpA Mesalamine Product Offerings
7.9.5 Erregierre SpA Recent Development
7.10 Corden Pharma Bergamo
7.10.1 Corden Pharma Bergamo Company Information
7.10.2 Corden Pharma Bergamo Introduction and Business Overview
7.10.3 Corden Pharma Bergamo Mesalamine Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Corden Pharma Bergamo Mesalamine Product Offerings
7.10.5 Corden Pharma Bergamo Recent Development
7.11 CTX Lifescience
7.11.1 CTX Lifescience Company Information
7.11.2 CTX Lifescience Introduction and Business Overview
7.11.3 CTX Lifescience Mesalamine Sales, Revenue and Gross Margin (2019-2024)
7.11.4 CTX Lifescience Mesalamine Product Offerings
7.11.5 CTX Lifescience Recent Development
7.12 Ishita Active Pharma Ingredients
7.12.1 Ishita Active Pharma Ingredients Company Information
7.12.2 Ishita Active Pharma Ingredients Introduction and Business Overview
7.12.3 Ishita Active Pharma Ingredients Mesalamine Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Ishita Active Pharma Ingredients Mesalamine Product Offerings
7.12.5 Ishita Active Pharma Ingredients Recent Development
7.13 YC Biotech (Jiangsu)
7.13.1 YC Biotech (Jiangsu) Company Information
7.13.2 YC Biotech (Jiangsu) Introduction and Business Overview
7.13.3 YC Biotech (Jiangsu) Mesalamine Sales, Revenue and Gross Margin (2019-2024)
7.13.4 YC Biotech (Jiangsu) Mesalamine Product Offerings
7.13.5 YC Biotech (Jiangsu) Recent Development
7.14 Xinxiang Tianfeng Fine Chemical
7.14.1 Xinxiang Tianfeng Fine Chemical Company Information
7.14.2 Xinxiang Tianfeng Fine Chemical Introduction and Business Overview
7.14.3 Xinxiang Tianfeng Fine Chemical Mesalamine Sales, Revenue and Gross Margin (2019-2024)
7.14.4 Xinxiang Tianfeng Fine Chemical Mesalamine Product Offerings
7.14.5 Xinxiang Tianfeng Fine Chemical Recent Development
8 Industry Chain Analysis
8.1 Mesalamine Industrial Chain
8.2 Mesalamine Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Mesalamine Sales Model
8.5.2 Sales Channel
8.5.3 Mesalamine Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
Syntese A/S
Divis Laboratories
Cambrex Corporation
Ipca Laboratories
Hangzhou Brother
PharmaZell
Lianyungang Fengheng Biopharm
Lasa Loboratory
Erregierre SpA
Corden Pharma Bergamo
CTX Lifescience
Ishita Active Pharma Ingredients
YC Biotech (Jiangsu)
Xinxiang Tianfeng Fine Chemical
*If Applicable.